394 related articles for article (PubMed ID: 23889668)
21. Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study.
Mavinkurve-Groothuis AM; Marcus KA; Pourier M; Loonen J; Feuth T; Hoogerbrugge PM; de Korte CL; Kapusta L
Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):562-9. PubMed ID: 23109647
[TBL] [Abstract][Full Text] [Related]
22. Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy.
Cadeddu C; Piras A; Dessì M; Madeddu C; Mantovani G; Scartozzi M; Hagendorff A; Colonna P; Mercuro G
Int J Cardiovasc Imaging; 2017 Feb; 33(2):197-207. PubMed ID: 27696298
[TBL] [Abstract][Full Text] [Related]
23. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review.
Thavendiranathan P; Poulin F; Lim KD; Plana JC; Woo A; Marwick TH
J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2751-68. PubMed ID: 24703918
[TBL] [Abstract][Full Text] [Related]
24. Assessment of left ventricular systolic dysfunction by tissue Doppler imaging to detect subclinical cardiomyopathy early after anthracycline therapy.
Lotrionte M; Palazzoni G; Natali R; Comerci G; Abbate A; Loperfido F; Biondi-Zoccai G
Minerva Cardioangiol; 2007 Dec; 55(6):711-20. PubMed ID: 18091640
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of anthracycline-induced subclinical LV dysfunction by using myocardial composite index and two-dimension speckle tracking echocardiography technique.
Zhu J; Xie S; Ji H; Gu X; Wu J
Front Cardiovasc Med; 2022; 9():936212. PubMed ID: 36035907
[TBL] [Abstract][Full Text] [Related]
26. Global longitudinal strain at 3 months after therapy can predict late cardiotoxicity in breast cancer.
Liu Z; Liu M; Zhong X; Qin Y; Liang T; Luo T; Yan X; Tang Z; Wang X; Liang S; Li Q; Ruan X; He W; Huang H
Cancer Med; 2023 Jun; 12(12):13374-13387. PubMed ID: 37183826
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Value of Cardiac Biomarkers Assessment in Combination with Myocardial 2D Strain Echocardiography for Early Detection of Anthracycline-Related Cardiac Toxicity.
Mahjoob MP; Sheikholeslami SA; Dadras M; Mansouri H; Haghi M; Naderian M; Sadeghi L; Tabary M; Khaheshi I
Cardiovasc Hematol Disord Drug Targets; 2020; 20(1):74-83. PubMed ID: 31513000
[TBL] [Abstract][Full Text] [Related]
28. Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy for the prediction of subsequent cardiotoxicity.
Charbonnel C; Convers-Domart R; Rigaudeau S; Taksin AL; Baron N; Lambert J; Ghez S; Georges JL; Farhat H; Lambert J; Rousselot P; Livarek B
Ann Cardiol Angeiol (Paris); 2016 Nov; 65(5):380. PubMed ID: 27968773
[TBL] [Abstract][Full Text] [Related]
29. Left ventricular strain and strain rates are decreased in children with normal fractional shortening after exposure to anthracycline chemotherapy.
Moon TJ; Miyamoto SD; Younoszai AK; Landeck BF
Cardiol Young; 2014 Oct; 24(5):854-65. PubMed ID: 24044518
[TBL] [Abstract][Full Text] [Related]
30. Baseline Global Longitudinal Strain as a Predictor of Left Ventricular Dysfunction and Hospitalization for Heart Failure of Patients With Malignant Lymphoma After Anthracycline Therapy.
Hatazawa K; Tanaka H; Nonaka A; Takada H; Soga F; Hatani Y; Matsuzoe H; Shimoura H; Ooka J; Sano H; Mochizuki Y; Matsumoto K; Hirata KI
Circ J; 2018 Sep; 82(10):2566-2574. PubMed ID: 29984789
[TBL] [Abstract][Full Text] [Related]
31. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab.
Sawaya H; Sebag IA; Plana JC; Januzzi JL; Ky B; Tan TC; Cohen V; Banchs J; Carver JR; Wiegers SE; Martin RP; Picard MH; Gerszten RE; Halpern EF; Passeri J; Kuter I; Scherrer-Crosbie M
Circ Cardiovasc Imaging; 2012 Sep; 5(5):596-603. PubMed ID: 22744937
[TBL] [Abstract][Full Text] [Related]
32. Early detection of epirubicin-induced cardiotoxicity in patients with breast cancer.
Florescu M; Magda LS; Enescu OA; Jinga D; Vinereanu D
J Am Soc Echocardiogr; 2014 Jan; 27(1):83-92. PubMed ID: 24268372
[TBL] [Abstract][Full Text] [Related]
33. Can comprehensive echocardiographic evaluation provide an advantage to predict anthracycline-induced cardiomyopathy?
Erdoğan D; Yücel H; Alanoğlu EG; Uysal BA; Koçer M; Ozaydın M; Doğan A
Turk Kardiyol Dern Ars; 2011 Dec; 39(8):646-53. PubMed ID: 22257802
[TBL] [Abstract][Full Text] [Related]
34. Global Longitudinal Strain Accuracy for Cardiotoxicity Prediction in a Cohort of Breast Cancer Patients During Anthracycline and/or Trastuzumab Treatment.
Gripp EA; Oliveira GE; Feijó LA; Garcia MI; Xavier SS; Sousa AS
Arq Bras Cardiol; 2018 Feb; 110(2):140-150. PubMed ID: 29561992
[TBL] [Abstract][Full Text] [Related]
35. Prediction of trastuzumab-induced cardiotoxicity in breast cancer patients receiving anthracycline-based chemotherapy.
El-Sherbeny WS; Sabry NM; Sharbay RM
J Echocardiogr; 2019 Jun; 17(2):76-83. PubMed ID: 30099714
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of cardiotoxicity via speckle-tracking echocardiography in patients treated with anthracyclines.
Dogru A; Cabuk D; Sahin T; Dolasik I; Temiz S; Uygun K
Onkologie; 2013; 36(12):712-6. PubMed ID: 24356562
[TBL] [Abstract][Full Text] [Related]
37. Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection.
Negishi K; Negishi T; Haluska BA; Hare JL; Plana JC; Marwick TH
Eur Heart J Cardiovasc Imaging; 2014 Mar; 15(3):324-31. PubMed ID: 24057661
[TBL] [Abstract][Full Text] [Related]
38. Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy.
Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Clarke JL; Thomas L
Eur Heart J Cardiovasc Imaging; 2013 Mar; 14(3):228-34. PubMed ID: 22782955
[TBL] [Abstract][Full Text] [Related]
39. Use of spectral tracking technique to evaluate the changes in left ventricular function in patients undergoing chemotherapy for colorectal cancer.
Wang Z; Qin W; Zhai Z; Huang L; Feng J; Guo X; Liu K; Zhang C; Wang Z; Lu G; Dong S
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1203-1213. PubMed ID: 33247369
[TBL] [Abstract][Full Text] [Related]
40. Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity.
Negishi K; Negishi T; Hare JL; Haluska BA; Plana JC; Marwick TH
J Am Soc Echocardiogr; 2013 May; 26(5):493-8. PubMed ID: 23562088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
